Literature DB >> 26621753

Unusual Sertoli Cell Tumor Associated With Sex Cord Tumor With Annular Tubules in Peutz-Jeghers Syndrome: Report of a Case and Review of the Literature on Ovarian Tumors in Peutz-Jeghers Syndrome.

Sanjita Ravishankar1, Shamlal Mangray2, Arlet Kurkchubasche2, Evgeny Yakirevich2, Robert H Young3.   

Abstract

We report the case of an 11-year-old girl with Peutz-Jeghers syndrome and a unilateral ovarian tumor most consistent with Sertoli cell tumor associated with sex cord tumor with annular tubules. The ovary was replaced by a lobular, solid, yellow tumor. Microscopic examination showed 2 components that focally merged. The first was composed of uniform, cytologically bland cells arranged mostly in diffuse sheets and focally in tubules. The second showed typical sex cord tumor with annular tubules with extensive calcification. The predominant component of the tumor clearly fell in the sex cord category and most closely resembled Sertoli cell tumor. This case adds to the limited information on ovarian sex cord tumors, other than typical sex cord tumor with annular tubules, arising in association with Peutz-Jeghers syndrome, a topic reviewed herein.
© The Author(s) 2015.

Entities:  

Keywords:  Peutz-Jeghers syndrome; Sertoli cell tumor; ovarian neoplasms; sex cord stromal tumors

Mesh:

Year:  2015        PMID: 26621753     DOI: 10.1177/1066896915620663

Source DB:  PubMed          Journal:  Int J Surg Pathol        ISSN: 1066-8969            Impact factor:   1.271


  2 in total

1.  Anti-Müllerian Hormone Type II Receptor Expression in Endometrial Cancer Tissue.

Authors:  Marek Gowkielewicz; Aleksandra Lipka; Marta Majewska; Aleksandra Piotrowska; Marta Szadurska-Noga; Jacek J Nowakowski; Marta Wiszpolska; Piotr Dzięgiel; Tomasz Wasniewski; Mariusz Krzysztof Majewski; Marcin Jozwik
Journal:  Cells       Date:  2020-10-17       Impact factor: 6.600

2.  A recurrence of advanced malignant sex cord tumor with annular tubules: case report.

Authors:  Ping Zheng; Jinhua Leng; Jinghe Lang
Journal:  Transl Cancer Res       Date:  2020-03       Impact factor: 1.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.